pharma · Endometrial Cancer · WHWK
Whitehawk Therapeutics
Whitehawk Therapeutics is a pharma organization headquartered in Morristown, USA. It trades on NYSE under ticker WHWK. Primary therapeutic focus areas include Endometrial Cancer. NovaPharmaNews links 1 clinical program(s
Morristown, USA HQ
24 Employees
Public company Type
WHWK · NYSE Ticker
Company details
- Status
- Public
- HQ
- Morristown, USA
- Employees
- 24
- Programs
- 1
- Drugs
- 0
- Patents
- 0
HWK-007
Phase 1 · small molecule · Endometrial Cancer
HWK-007 for Endometrial Cancer is a Phase 1 program (small_molecule) at Whitehawk Therapeutics with 1 ClinicalTrials.gov record(s).
Internal code HWK-007-101
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Whitehawk Therapeutics
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Endometrial Cancer
- Status
- active
- Trials
- 1